Pharmacogenetic Study of the Impact of ABCB1 Single-Nucleotide Polymorphisms on Lenalidomide Treatment Outcomes in Patients With Multiple Myeloma: Results From a Phase IV Observational Study and Subsequent Phase II Clinical Trial

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-017-3481-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical and Biomarker Outcomes of the Phase II Vandetanib Study From the BATTLE Trial

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

Phase I/Ii Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients With High Risk (HR) Multiple Myeloma (MM)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Phase II Trial to Investigate Efficacy and Safety of Bendamustine, Dexamethasone and Thalidomide in Relapsed or Refractory Multiple Myeloma Patients After Treatment With Lenalidomide and Bortezomib

British Journal of Haematology
Hematology
2018English

Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Relapsed or Refractory Multiple Myeloma: A Phase 1b Study

American Journal of Hematology
Hematology
2019English

Phase I Trial of Lenalidomide and CCI-779 in Patients With Relapsed Multiple Myeloma: Evidence for Lenalidomide–CCI-779 Interaction via P-Glycoprotein

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Phase II Trial of Karenitecin in Patients With Malignant Melanoma: Clinical and Translational Study

Clinical Cancer Research
Cancer ResearchOncology
2005English

Melphalan, Lenalidomide and Dexamethasone for the Treatment of Immunoglobulin Light Chain Amyloidosis: Results of a Phase II Trial

Haematologica
Hematology
2012English

Phase I/Ii Study of Carfilzomib, Bendamustine, and Dexamethasone (CBD) in Patients With Newly Diagnosed Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2020English

A Phase II Trial of Pan-Kir2d Blockade With IPH2101 in Smoldering Multiple Myeloma

Haematologica
Hematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy